Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2+ Resectable Esophagogastric Cancer

Not yet recruiting

1 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
- HER2 positive gastric cancer
Investigated Drugs:
Study of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy

Not yet recruiting

2 1 1 1
Investigated Drugs:
Study on [68Ga]Ga-FAPI-46 PET/CT Imaging for Better Diagnosis in Patients with Pancreatic and Gastroesophageal Cancer

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
- Pancreatic carcinoma
Investigated Drugs:
- Iodixanol
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

Not recruiting

2 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
- Oesophageal adenocarcinoma
Investigated Drugs:
Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Not recruiting

4 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
Investigated Drugs:
Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Nivolumab
+4
Study of Retifanlimab, Capecitabine, and Oxaliplatin for First-Line Treatment in Patients with Metastatic Esophagogastric Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Gastrointestinal cancer metastatic
- Gastrooesophageal cancer
Investigated Drugs:
- Retifanlimab
Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
Investigated Drugs:
- Regorafenib
- Nivolumab
Study on [68Ga]Ga-FAPI-46 and Iodixanol for Better Imaging in Patients with Pancreatic and Gastroesophageal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
- Pancreatic carcinoma
Investigated Drugs:
- Iodixanol
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
- Gastric cancer
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
- Fludeoxyglucose (18F)

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies